Cargando…
A cross‐sectional natural history study of aspartylglucosaminuria
Aspartylglucosaminuria (AGU) is a rare lysosomal storage disorder that causes stagnation of development in adolescence and neurodegeneration in early adulthood. Precision therapies, including gene transfer therapy, are in development with a goal of taking advantage of the slow clinical course. Under...
Autores principales: | Goodspeed, Kimberly, Horton, Daniel, Lowden, Andrea, Sguigna, Peter V., Booth, Timothy, Wang, Zhiyue J., Edgar, Veronica Bordes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458605/ https://www.ncbi.nlm.nih.gov/pubmed/36101820 http://dx.doi.org/10.1002/jmd2.12294 |
Ejemplares similares
-
Optical coherence tomography features in brothers with aspartylglucosaminuria
por: Goodspeed, Kimberly, et al.
Publicado: (2018) -
Carlos II of Spain, ‘The Bewitched’: cursed by aspartylglucosaminuria?
por: Martin, Andrew, et al.
Publicado: (2021) -
Identification of Small Molecule Compounds for Pharmacological Chaperone Therapy of Aspartylglucosaminuria
por: Banning, Antje, et al.
Publicado: (2016) -
Effectiveness of early hematopoietic stem cell transplantation in preventing neurocognitive decline in aspartylglucosaminuria: A case series
por: Selvanathan, Arthavan, et al.
Publicado: (2021) -
Statistical Permutation Test Reveals Progressive and Region-Specific Iron Accumulation in the Thalami of Children with Aspartylglucosaminuria
por: Sairanen, Viljami, et al.
Publicado: (2020)